Draft:Asteromorph


Asteromorph Inc.
Native name
아스테로모프
Company type
Private
IndustryArtificial intelligence
FoundedFebruary 2025
HeadquartersSeoul, South Korea
Key people
Minhyeong Lee (CEO), Suyoung Hwang (CTO)
ProductsSpacer (AI research system)
WebsiteOfficial website

Asteromorph Inc. is a South Korean artificial intelligence (AI) research company based in Seoul. The company was established in February 2025 and develops AI foundation models for scientific research.

History

Asteromorph was founded in February 2025 by Minhyeong Lee and Suyoung Hwang. The company goal as the development of "Scientific Superintelligence".

In April 2025, the company raised 5 billion KRW (approx. 3.7 million USD) in a seed funding round. The investment was led by FuturePlay, with participation from Korea Investment Partners and Mirae Asset Venture Investment.

Technology

The company's primary product is an AI system called Spacer.

In August 2025, Asteromorph released a case study involving the use of its AI to generate hypotheses for liver cancer suppression.


Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.